Market Rumors: GlaxoSmithKline, Keppel, Jasmine Broadband
GlaxoSmithKline PLC, the U.K.'s biggest drugmarker, is looking to sell its first euro bonds since 2009 and is currently marketing €2.5 billion ($3.1 billion) of notes maturing in five and 10...To view the full article, register now.
Already a subscriber? Click here to view full article